| Expressions of CD8+TILs, PD-L1 and Foxp3+TILs in stage I NSCLC guiding adjuvant chemotherapy decisions | |
| Teng, Feifei; Meng, Xiangjiao; Wang, Xin; Yuan, Jupeng; Liu, Sujing; Mu, Dianbin; Zhu, Hui; Kong, Li; Yu, Jinming | |
| 刊名 | ONCOTARGET
 |
| 2016 | |
| 卷号 | 7期号:39页码:64318-64329 |
| 关键词 | non-small cell lung cancer TILs PD-L1 Foxp3 adjuvant chemotherapy |
| DOI | 10.18632/oncotarget.11793 |
| URL标识 | 查看原文 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/4711503 |
| 专题 | 山东大学 |
| 作者单位 | Shandong Univ, Shandong Canc Hosp & Inst, Dept Radiat Oncol, |
| 推荐引用方式 GB/T 7714 | Teng, Feifei,Meng, Xiangjiao,Wang, Xin,et al. Expressions of CD8+TILs, PD-L1 and Foxp3+TILs in stage I NSCLC guiding adjuvant chemotherapy decisions[J]. ONCOTARGET,2016,7(39):64318-64329. |
| APA | Teng, Feifei.,Meng, Xiangjiao.,Wang, Xin.,Yuan, Jupeng.,Liu, Sujing.,...&Yu, Jinming.(2016).Expressions of CD8+TILs, PD-L1 and Foxp3+TILs in stage I NSCLC guiding adjuvant chemotherapy decisions.ONCOTARGET,7(39),64318-64329. |
| MLA | Teng, Feifei,et al."Expressions of CD8+TILs, PD-L1 and Foxp3+TILs in stage I NSCLC guiding adjuvant chemotherapy decisions".ONCOTARGET 7.39(2016):64318-64329. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论